NCT05900934

Brief Summary

In this study, the investigators plan to have Parkinson's patients perform exercises according to the task-oriented training method. Since recent studies have suggested that task-oriented training should be organized as a series of workstations that allow for more intensive practice, each of them has a program content implemented in the form of a station. The program will be implemented in 11 different stations with 3 minutes and a 1-minute break at each station, 3 days a week for 8 weeks under the supervision and guidance of a physiotherapist. The task-oriented training program will be carried out by applying the above-mentioned exercises in the form of stations sequentially within a certain period of time. For all exercises, the intensity perceived by the individuals will be ensured to be 12-15 points of perceived exertion according to the Borg Perceived Exertion Scale. In this way, the exercise program can be easily individualized according to the participant's pain, complaints, and functional status. In the study, after the task-oriented approach, foam roller application and myofascial release will be applied at the end of each session. Foam roller application; C7-T1 and posterior neck region, thoracic spine, lumbar spine, and right and left sides of the thoracolumbar spine will be applied with a foam roller, which is a myofascial release device, in each session. Each application area will be applied in 3 sets of 60 seconds of application and 30 seconds of rest. The intensity of the pressure for the intensity of the application will be subjectively controlled with a target numeric rating scale rating of 7/10 (0 represents no discomfort and 10 represents maximum discomfort). In the sham group, similar to the literature, the intensity of the application will be applied in accordance with the 0/10 numeric rating scale, at the same application sites, for the same duration and the same rest intervals. Within the scope of this study, participants gait, balance, rotation time, range of motion, level of achievement of the treatment goal, quality of life and trunk impairment will be evaluated at the beginning of the study and at the end of 8 weeks.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 13, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

June 15, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2024

Completed
Last Updated

February 29, 2024

Status Verified

February 1, 2024

Enrollment Period

1 year

First QC Date

May 23, 2023

Last Update Submit

February 26, 2024

Conditions

Keywords

myofascial releasinggaitbalance

Outcome Measures

Primary Outcomes (1)

  • GAITRite® gait system

    Evaluation of time-distance characteristics of gait

    Eight week

Secondary Outcomes (10)

  • Berg Balance Scale

    Eight week

  • Posturographic assessment

    Eight week

  • The Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale

    Eight week

  • Roll-over test

    Eight week

  • Range of Motion Assessment

    Baseline- End of the eight week

  • +5 more secondary outcomes

Study Arms (2)

Myofascial Releasing Group

ACTIVE COMPARATOR

The intensity of application is important for foam rollers. For intensity, the intensity of the pressure will be determined by a subjective 7/10 target numeric rating scale rating (0 representing no discomfort and 10 representing maximum discomfort) and applied at the end of each session.

Other: Myofascial Releasing Group

Sham Myofascial Releasing Group

SHAM COMPARATOR

In the sham group, similar to the literature, the intensity will be applied with foam rollers in accordance with the 0/10 numerical rating scale, to the same application areas, for the same duration and with the same rest intervals.

Other: Sham Myofascial Releasing Group

Interventions

Using a subjective 7/10 target numeric rating scale rating (0 representing no discomfort and 10 representing maximum discomfort), the intensity of foam roller application can be determined. This intensity defines an application intensity that is mildly painful for the participant and appropriate according to previous literature.

Also known as: Myofascial Release
Myofascial Releasing Group

The severity of the application is not felt at all according to the numerical rating scale of 0/10.

Also known as: Sham Myofascial Release
Sham Myofascial Releasing Group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with "Parkinson's Disease" by a specialist physician,
  • In a stable period in terms of motor fluctuations and drug treatment
  • Severity of the disease (1-3 according to Hoehn \& Yahr) staging
  • No other neurological disease
  • Cognitive status of 24 and above according to the Mini-Mental State Evaluation (MMSE) test
  • No change in Parkinson's disease-related medications or doses during the study
  • Volunteering to participate in the study and giving written informed consent

You may not qualify if:

  • Hearing and visual impairment, orthopedic, cardiopulmonary and additional neurological diseases that prevent participation in exercises
  • Lack of independent ambulation
  • Using a brain pacemaker for Parkinson's disease
  • Continue with another rehabilitation program
  • The occurrence of any health problem during the assessments and exercise training
  • Failure to attend three consecutive sessions and a total of five sessions during the 24-session treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, 06590, Turkey (Türkiye)

Location

Related Publications (1)

  • Kasli K, Dogan M, Ozal C, Dogan Y, Kilinc M, Aksu Yildirim S. The effects of myofascial release in combined with task-oriented circuit training on balance in people with Parkinson's disease: a randomized pilot trial. Neurol Res. 2024 Sep;46(9):848-858. doi: 10.1080/01616412.2024.2360860. Epub 2024 May 31.

MeSH Terms

Conditions

Parkinson DiseaseMovement Disorders

Interventions

Myofascial Release Therapy

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Yahya Doğan, Dr

    Hacettepe University

    PRINCIPAL INVESTIGATOR
  • Muhammed Kılınç, Prof

    Hacettepe University

    STUDY CHAIR
  • Mert Doğan, PhD

    Akdeniz University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
A double-blind, assessor-blinded and patient-blinded, randomized controlled study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Arm 1: Myofascial Releasing Group Arm 2: Sham Myofascial Releasing Group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 23, 2023

First Posted

June 13, 2023

Study Start

June 15, 2023

Primary Completion

June 15, 2024

Study Completion

September 15, 2024

Last Updated

February 29, 2024

Record last verified: 2024-02

Locations